Molecular analysis in a patient with severe factor VII deficiency and an inhibitor: report of a novel mutation (S103G)

Eur J Haematol. 2007 Oct;79(4):354-9. doi: 10.1111/j.1600-0609.2007.00916.x. Epub 2007 Aug 10.

Abstract

Congenital factor VII (FVII) deficiency is an autosomal recessive bleeding disorder with variable phenotypic correlation between FVII activity and bleeding risk. We report a novel mutation of the FVII gene that creates the amino acid change Ser 103 to Gly, which resulted in severe FVII deficiency with reduced FVII antigen. This mutation in the heterozygous form was also present in a mildly affected, unrelated patient. We also report on the natural history of an FVII inhibitor in the patient with severe FVII deficiency.

Publication types

  • Case Reports
  • Clinical Trial

MeSH terms

  • Amino Acid Substitution* / immunology
  • Blood Coagulation Factor Inhibitors / immunology
  • DNA Mutational Analysis
  • Factor VII / genetics*
  • Factor VII / immunology
  • Factor VII Deficiency / genetics*
  • Factor VII Deficiency / immunology
  • Hemorrhage / genetics
  • Hemorrhage / immunology
  • Heterozygote
  • Humans
  • Mutation, Missense* / immunology
  • Phenotype
  • Severity of Illness Index

Substances

  • Blood Coagulation Factor Inhibitors
  • Factor VII